Published in Infect Immun on June 01, 1972
Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun (1979) 2.21
Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella. Infect Immun (1975) 2.16
Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes. Infect Immun (1975) 1.74
Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium. Infect Immun (1976) 1.63
Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium. Infect Immun (1973) 1.48
Immunoprotective activity of ribosomes from Haemophilus influenzae. Infect Immun (1977) 1.44
Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum. Infect Immun (1974) 1.38
Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect Immun (1981) 1.38
Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun (1981) 1.33
Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium. Infect Immun (1976) 1.32
Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae. Infect Immun (1978) 1.32
Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity. Infect Immun (1978) 1.22
Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium. Infect Immun (1977) 1.21
Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides. Immunology (1974) 1.17
Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium. Infect Immun (1979) 1.16
The immunogenic activity of ribosomal fractions derived from Brucella abortus. J Hyg (Lond) (1976) 1.14
Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions. Infect Immun (1979) 1.02
Immunogenicity of the ribosomal fraction of Salmonella typhimurium: analysis of humoral immunity. Infect Immun (1980) 1.02
Immunity to Salmonella typhimurium infection: characterization of antigens in active protection by polyacrylamide gel electrophoresis. Infect Immun (1973) 1.00
Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine. Infect Immun (1977) 0.98
Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans. Infect Immun (1978) 0.97
Immunogenicity of ribosomal preparations from Neisseria gonorrhoeae. Infect Immun (1980) 0.94
Protective ability of Salmonella ribosomal protein and RNA in inbred mice. Infect Immun (1978) 0.94
Humoral and cell-mediated responses to a ribosomal preparation from Streptococcus mutans. Infect Immun (1982) 0.94
Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations. Infect Immun (1979) 0.93
Immunogenicity of ribosomes from enzymatically lysed Streptococcus pyogenes. Infect Immun (1980) 0.91
Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect Immun (1991) 0.83
Opsonization and phagocytosis of Haemophilus influenzae type B organisms by mouse polymorphonuclear leucocytes and antiribosomal serum. Br J Exp Pathol (1983) 0.81
Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid. Infect Immun (1981) 0.79
A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens. J Immunol Methods (2011) 0.78
Antigenic modification: its relation to protective host resistance in murine salmonellosis. Infect Immun (1981) 0.77
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Mechanisms of acquired resistance in mouse typhoid. J Exp Med (1966) 9.20
Studies on the nutrition and physiology of Pasteurella pestis. VI. A differential plating medium for the estimation of the mutation rate to avirulence. J Bacteriol (1961) 9.14
New color reactions for determination of sugars in polysaccharides. Methods Biochem Anal (1955) 7.97
Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun (1970) 5.96
IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1965) 4.16
Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis. J Bacteriol (1966) 3.07
Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium. J Bacteriol (1969) 2.72
Immunogenicity of Ribonucleic Acid Preparations Obtained from Salmonella typhimurium. Infect Immun (1970) 2.54
Protection against pneumococcal infection by a ribosomal preparation. Infect Immun (1971) 2.49
Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations. J Bacteriol (1969) 2.35
Extraction and isolation of individual ribosomal proteins from Escherichia coli. J Bacteriol (1968) 2.27
Pesticins. II. Production of pesticin I and II. J Bacteriol (1962) 1.98
Immunity induced by ribosomal extracts from Staphylococcus aureus. J Reticuloendothel Soc (1970) 1.94
Antibacterial immunity induced by ribosomal vaccines. J Reticuloendothel Soc (1970) 1.68
Experimental salmonellosis: differential passive transfer of immunity with serum and cells obtained from ribosomal and ribonucleic acid-immunized mice. J Reticuloendothel Soc (1971) 1.31
Failure of synthetic polynucleotides to affect the immunogenicity of mycobacterial ribonucleic Acid and ribosomal protein preparations. Infect Immun (1971) 1.28
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med (1999) 5.61
Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet (1972) 2.99
Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther (2001) 2.95
Genetic foundations of human intelligence. Hum Genet (2009) 2.71
A high molecular weight antigen in Legionnaires' disease bacterium: isolation and partial characterization. Ann Intern Med (1979) 2.29
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology (2001) 2.27
Interaction of Legionella pneumophila with Acanthamoeba castellanii: uptake by coiling phagocytosis and inhibition of phagosome-lysosome fusion. Infect Immun (1996) 2.19
The sand seas of Titan: Cassini RADAR observations of longitudinal dunes. Science (2006) 2.11
Fatalities during remission of childhood leukemia. Blood (1972) 2.08
Genetic characterization of antimicrobial resistance in Canadian isolates of Salmonella serovar Typhimurium DT104. Antimicrob Agents Chemother (1999) 2.03
Legionnaires' disease associated with a hospital water system: a cluster of 24 nosocomial cases. Ann Intern Med (1983) 2.00
Differing opinions of raw food diet research. J Am Vet Med Assoc (2001) 1.95
Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J (2000) 1.94
The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J (1999) 1.94
Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant (2001) 1.92
Multiresistant Salmonella Typhimurium DT104 infections of humans and domestic animals in the Pacific Northwest of the United States. Epidemiol Infect (2000) 1.89
Salmonella typhimurium DT104: a virulent and drug-resistant pathogen. Can Vet J (1998) 1.87
Serospecificity and opsonic activity of antisera to Legionella pneumophila. Infect Immun (1979) 1.83
Virulence conversion of Legionella pneumophila serogroup 1 by passage in guinea pigs and embryonated eggs. Infect Immun (1982) 1.81
Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther (1998) 1.77
Adult Gaucher's disease: kindred studies and demonstration of a deficiency of acid beta-glucosidase in cultured fibroblasts. Am J Hum Genet (1972) 1.74
Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes. Infect Immun (1975) 1.74
Repair and reconstruction of the anterior cruciate ligament in dogs. Factors influencing long-term results. J Bone Joint Surg Am (1971) 1.74
Soldier performance and strenuous road marching: influence of load mass and load distribution. Mil Med (1997) 1.72
Immunological and biochemical relationships among flagella isolated from Legionella pneumophila serogroups 1, 2, and 3. Infect Immun (1981) 1.61
Characterization of the selective inhibition of growth of virulent Legionella pneumophila by supplemented Mueller-Hinton medium. Infect Immun (1989) 1.61
Virulence conversion of Legionella pneumophila: a one-way phenomenon. Infect Immun (1988) 1.59
Bile duct injury during laparoscopic cholecystectomy: a report of the Standards Sub-committee of the Victorian State Committee of the Royal Australasian College of Surgeons. Aust N Z J Surg (1993) 1.53
Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium. Infect Immun (1973) 1.48
Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect Immun (1999) 1.46
Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction. Infect Immun (1976) 1.46
Testing Hardy-Weinberg equilibrium on allelic data from VNTR loci. Am J Hum Genet (1992) 1.45
Ultrastructural localization and protective activity of a high-molecular-weight antigen isolated from Legionella pneumophila. Infect Immun (1981) 1.44
Legionnaires' disease in pneumonia patients in Iowa. A retrospective seroepidemiologic study, 1972-1977. Ann Intern Med (1979) 1.44
Elevated levels of cesium-137 in common mushrooms (Agaricaceae) with possible relationship to high levels of cesium-137 in Whitetail deer, 1968-1969. Radiol Health Data Rep (1970) 1.39
Creative thinking in nursing education: preparing for tomorrow's challenges. Nurs Outlook (1999) 1.39
Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project. Can J Infect Dis (1997) 1.34
Comparative features of pneumococcal, mycoplasmal, and Legionnaires' disease pneumonias. Ann Intern Med (1979) 1.32
Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium. Infect Immun (1976) 1.32
Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.30
The effects of noncontingent and contingent attention for self-injury, manding, and collateral responses. Behav Modif (1998) 1.30
Serospecific antigens of Legionella pneumophila. J Bacteriol (1986) 1.27
Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab (2011) 1.25
Cytotoxicity of extracellular Legionella pneumophila. Infect Immun (1994) 1.25
Renal tumors in the neonatal period. Cancer (1968) 1.25
Smoking and prostate cancer: findings from an Australian case-control study. Ann Oncol (2001) 1.24
Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium. Infect Immun (1977) 1.21
Site in cell-free protein synthesis sensitive to diphtheria toxin. J Bacteriol (1968) 1.18
Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium. Infect Immun (1979) 1.16
Adherence of Legionella pneumophila to guinea pig peritoneal macrophages, J774 mouse macrophages, and undifferentiated U937 human monocytes: role of Fc and complement receptors. Infect Immun (1992) 1.13
Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop Relat Res (1994) 1.13
Comparing apples with oranges. Arch Intern Med (1998) 1.12
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
Epidemiologic subtyping of Escherichia coli serogroup O157 strains isolated in Ontario by phage typing and pulsed-field gel electrophoresis. J Clin Microbiol (2000) 1.12
Proteolipid protein is necessary in peripheral as well as central myelin. Neuron (1997) 1.11
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Birth certificate data: how reliable? S D J Med (1984) 1.10
Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools. J Clin Microbiol (2001) 1.09
Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators. J Clin Microbiol (1998) 1.09
Stronger influence of maternal than paternal obesity on infant and early childhood body mass index: the Fels Longitudinal Study. Pediatr Obes (2012) 1.08
Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources. J Clin Microbiol (1995) 1.08
The application of molecular and immunologic techniques to study the epidemiology of Legionella pneumophila serogroup 1. Diagn Microbiol Infect Dis (1990) 1.07
Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function. Am J Physiol (1995) 1.07
Association of leukemia with radium groundwater contamination. JAMA (1985) 1.06
Baker's cysts mimicking the symptoms of deep vein thrombosis: diagnosis with venous duplex scanning. J Vasc Surg (1997) 1.05
Ferric reductases of Legionella pneumophila. Biometals (1993) 1.05
Isolation of a low-molecular-weight antibacterial system from human amniotic fluid. Infect Immun (1976) 1.04
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci (Lond) (2001) 1.04
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut (1999) 1.03
Analysis of proteins and glycoproteins at the picomole level by on-line coupling of microbore high-performance liquid chromatography with flow fast atom bombardment and electrospray mass spectrometry: a comparative evaluation. Biomed Environ Mass Spectrom (1990) 1.02
Sporadic Legionnaires' disease: clinical observations on 87 nosocomial and community-acquired cases. Am J Med Sci (1984) 1.02
Lung edema caused by high peak inspiratory pressures in dogs. Role of increased microvascular filtration pressure and permeability. Am Rev Respir Dis (1990) 1.01
Efficacy of oral and systemic antibiotic prophylaxis in colorectal operations. Arch Surg (1983) 1.01
Identification of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis, arcobacter butzleri, and A. butzleri-like species based on the glyA gene. J Clin Microbiol (2000) 1.01
Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease. Am J Med (1977) 1.00
Renal artey stenosis in renal transplantation. Med J Aust (1971) 1.00
Bacterial growth inhibition by amniotic fluid. III. Demonstration of the variability of bacterial growth inhibition by amniotic fluid with a new plate-count technique. Am J Obstet Gynecol (1975) 0.99
Cervical Rib with marked Vascular Symptoms. Proc R Soc Med (1914) 0.99
Proceedings: Splenectomy and chemotherapy in acute myelocytic leukemia of childhood. Cancer (1974) 0.99
Linkage disequilibrium between functionally related enzyme loci of Drosophila mojavensis. Can J Genet Cytol (1976) 0.99
Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol (1992) 0.97
Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97
Antibody-independent binding of complement component C1q by Legionella pneumophila. Infect Immun (1995) 0.96
Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96
Fatal "iron heart" in an adolescent: biochemical and ultrastructural aspects of the heart. Pediatrics (1975) 0.96
Indirect immunofluorescence antibodies to Legionella pneumophila: frequency in a rural community. J Clin Microbiol (1980) 0.96
Non-Hodgkin's lymphoma in children. Br J Cancer Suppl (1975) 0.95
Usefulness of angioplasty during acute myocardial infarction in patients with prior coronary artery bypass grafting. Am J Cardiol (1990) 0.95
The thyroid hormone receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors. Endocrinology (1998) 0.94
Sequential test selection in the analysis of abdominal pain. Med Decis Making (1996) 0.94
Lye injuries of the esophagus. Analysis of ninety cases of lye ingestion. J Thorac Cardiovasc Surg (1969) 0.94
Protective ability of Salmonella ribosomal protein and RNA in inbred mice. Infect Immun (1978) 0.94
The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells. Mutat Res (1997) 0.93
The contribution of feeding mode to obesogenic growth trajectories in American Samoan infants. Pediatr Obes (2013) 0.93
The effect of a curfew on pediatric out-of-hospital EMS responses. Prehosp Emerg Care (1998) 0.93
Methodology for in-process determination of residual water in freeze-dried products. Dev Biol Stand (1992) 0.92
Gastric carcinoid (gastrinoma) associated with achlorhydria (pernicious anemia). Cancer (1983) 0.92